Indapta Therapeutics Inc.

Houston, TX

UEI
FW7PJD4KQXC7
CAGE
7TP66
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
5000 Gulf Fwy bldg 5, Houston, TX 77023, USA
Website
indapta.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Immuno oncology product for multiple myeloma: g-NK cellular therapy to optimize monoclonal antibody efficacy in… R43CA235786 National Cancer Institute (NIH) $300,000
Translational development of specialized NK cells for cancer immunotherapy R41CA235924 National Cancer Institute (NIH) $300,000

Quick answers

Is Indapta Therapeutics Inc. registered in SAM.gov?

Yes. Indapta Therapeutics Inc.'s SAM.gov registration is active through March 26, 2027.

What is Indapta Therapeutics Inc.'s most recent federal award?

Indapta Therapeutics Inc.'s most recent federal grant award is Immuno oncology product for multiple myeloma: g-NK cellular therapy to optimize monoclonal antibody efficacy in… (R43CA235786), from National Cancer Institute (NIH), on May 15, 2019.

On GovTribe

See Indapta Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login